AACE/ACE algorithm: In type 2 diabetes, address multifactorial risk management
Alan J. Garber
PHILADELPHIA — In treating adults with prediabetes or type 2 diabetes, clinicians must consider and work to treat all risk factors for conversion to overt type 2 diabetes and its related macrovascular and microvascular complications, according to a speaker here.
Lifestyle modification underlies all therapies for a person with type 2 diabetes, and it must remain the central focus of any management effort, Alan J. Garber, MD, PhD, MACE, professor in the departments of medicine, biochemistry and molecular biology, and molecular and cellular biology at Baylor College of
PHILADELPHIA — In treating adults with prediabetes or type 2 diabetes, clinicians must consider and work to treat all risk factors for conversion to overt type 2 diabetes and its related macrovascular and microvascular complications, according to a speaker here.
Lifestyle modification underlies all therapies for a person with type 2 diabetes, and it must remain the central focus of any management effort, Alan J. Garber, MD, PhD, MACE, professor in the departments of medicine, biochemistry and molecular biology, and molecular and cellular biology at Baylor College of